[1]
|
Rahman, F., Kwan, G.F. and Benjamin, E.J. (2014) Global Epidemiology of Atrial Fibrillation. Nature Reviews Cardiology, 11, 639-654. https://doi.org/10.1038/nrcardio.2014.118
|
[2]
|
Guo, Y., Tian, Y., Wang, H., et al. (2015) Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China: New Insights into the Global Burden of Atrial Fibrillation. Chest, 147, 109-119. https://doi.org/10.1378/chest.14-0321
|
[3]
|
Wang, X., Fu, Q., Song, F., et al. (2018) Prevalence of Atrial Fibrillation in Different Socioeconomic Regions of China and Its Association with Stroke: Results from a National Stroke Screening Survey. International Journal of Cardiology, 271, 92-97. https://doi.org/10.1016/j.ijcard.2018.05.131
|
[4]
|
Jagadish, P.S., Kirolos, I., Khare, S., et al. (2019) Post-Operative Atrial Fibrillation: Should We Anticoagulate? Annals of Translational Medicine, 7, 407. https://doi.org/10.21037/atm.2019.07.10
|
[5]
|
Kirchhof, P., Benussi, S., Kotecha, D., et al. (2017) 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Revista Española de Cardiología, 70, 50.
https://doi.org/10.1016/j.rec.2017.07.009
|
[6]
|
Bjorck, S., Palaszewski, B., Friberg, L., et al. (2013) Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study. Stroke, 44, 3103-3108. https://doi.org/10.1161/STROKEAHA.113.002329
|
[7]
|
Calkins, H., Kuck, K.H., Cappato, R., et al. (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-Up, Definitions, Endpoints, and Research Trial Design. Journal of Interventional Cardiac Electrophysiology, 33, 171-257. https://doi.org/10.1007/s10840-012-9672-7
|
[8]
|
Yaghi, S., Boehme, A.K., Hazan, R., et al. (2016) Atrial Cardiopathy and Cryptogenic Stroke: A Cross-Sectional Pilot Study. Journal of Stroke and Cerebrovascular Diseases, 25, 110-114.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.001
|
[9]
|
Brambatti, M., Connolly, S.J., Gold, M.R., et al. (2014) Temporal Relationship between Subclinical Atrial Fibrillation and Embolic Events. Circulation, 129, 2094-2099. https://doi.org/10.1161/CIRCULATIONAHA.113.007825
|
[10]
|
Mitchell, L.B., Southern, D.A., Galbraith, D., et al. (2014) Prediction of Stroke or TIA in Patients without Atrial Fibrillation Using CHADS2 and CHA2DS2-VASc Scores. Heart, 100, 1524-1530.
https://doi.org/10.1136/heartjnl-2013-305303
|
[11]
|
Overvad, T.F., Nielsen, P.B., Larsen, T.B., et al. (2016) Left Atrial Size and Risk of Stroke in Patients in Sinus Rhythm. A Systematic Review. Thrombosis and Haemostasis, 116, 206-219. https://doi.org/10.1160/TH15-12-0923
|
[12]
|
T andon, K., Tirschwell, D., Longstreth, W.T., et al. (2019) Embolic Stroke of Undetermined Source Correlates to Atrial Fibrosis without Atrial Fibrillation. Neurology, 93, e381-e387. https://doi.org/10.1212/WNL.0000000000007827
|
[13]
|
Calkins, H., Hindricks, G., Cappato, R., et al. (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm: The Official Journal of the Heart Rhythm Society, 14, e275-e444.
|
[14]
|
Friberg, L., Tabrizi, F. and Englund, A. (2016) Catheter Ablation for Atrial Fibrillation Is Associated with Lower Incidence of Stroke and Death: Data from Swedish Health Registries. European Heart Journal, 37, 2478-2487.
https://doi.org/10.1093/eurheartj/ehw087
|
[15]
|
Saliba, W., Schliamser, J.E., Lavi, I., Barnett-Griness, O., Gronich, N. and Rennert, G. (2017) Catheter Ablation of Atrial Fibrillation Is Associated with Reduced Risk of Stroke and Mortality: A Propensity Score-Matched Analysis. Heart Rhythm, 14, 635-642. https://doi.org/10.1016/j.hrthm.2017.02.001
|
[16]
|
Packer, D.L., Mark, D.B., Robb, R.A., Monahan, K.H., Bahnson, T.D., Poole, J.E., et al. (2019) Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA, 321, 1261-1274.
https://doi.org/10.1001/jama.2019.0693
|
[17]
|
Själander, S., Holmqvist, F., Smith, J., et al. (2017) Assessment of Use vs Discontinuation of Oral Anticoagulation after Pulmonary Vein Isolationin Patients with Atrial Fibrillation. JAMA Cardiology, 2, 146-152.
https://doi.org/10.1001/jamacardio.2016.4179
|
[18]
|
Marchlinski, F.E. and Santangeli, P. (2017) When Does High Risk for Stroke Become Low Risk after Atrial Fibrillation Ablation? JAMA Cardiology, 2, 152-154. https://doi.org/10.1001/jamacardio.2016.4228
|
[19]
|
Themistoclakis, S., Corrado, A., Marchlinski, F.E., Jais, P., Zado, E., Rossillo, A., et al. (2010) The Risk of Thromboembolism and Need for Oral Anticoagulation after Successful Atrial Fibrillation Ablation. Journal of the American College of Cardiology, 55, 735-743. https://doi.org/10.1016/j.jacc.2009.11.039
|
[20]
|
Liang, J.J., Elafros, M.A., Mullen, M.T., Muser, D., Hayashi, T., Enriquez, A., et al. (2018) Anticoagulation Use and Clinical Outcomes after Catheter Ablation in Patients with Persistent and Longstanding Persistent Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 29, 823-832. https://doi.org/10.1111/jce.13476
|
[21]
|
Romero, J., Cerrud-Rodriguez, R.C., Diaz, J.C., et al. (2019) Oral Anticoagulation after Catheter Ablation of Atrial Fibrillation and the Associated Risk of Thromboembolic Events and Intracranial Hemorrhage: A Systematic Review and Meta-Analysis. Journal of Cardiovascular Electrophysiology, 30, 1250-1257. https://doi.org/10.1111/jce.14052
|
[22]
|
Yu, R., Xi, H., Lu, J., et al. (2020) Real-World Investigation on Discontinuation of Oral Anticoagulation after Paroxysmal Atrial Fibrillation Catheter Ablation in China. Annals of Palliative Medicine, 9, 940-946.
https://doi.org/10.21037/apm-20-565
|
[23]
|
Birnie, D.H., Smith, E.E. and Verma, A. (2019) To Continue or Stop Oral Anti-Coagulation in Higher-Risk Patients after a “Successful” AF Ablation; That Is the Question. Journal of Cardiovascular Electrophysiology, 30, 1258-1260.
https://doi.org/10.1111/jce.14056
|
[24]
|
Freeman, J.V., Shrader, P., Pieper, K.S., et al. (2019) Outcomes and Anticoagulation Use after Catheter Ablation for Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 12, e007612.
https://doi.org/10.1161/CIRCEP.119.007612
|
[25]
|
Yang, W.Y., Du, X., Jiang, C., et al. (2020) The Safety of Discontinuation of Oral Anticoagulation Therapy after Apparently Successful Atrial Fibrillation Ablation: A Report from the Chinese Atrial Fibrillation Registry Study. Europace, 22, 90-99. https://doi.org/10.1093/europace/euz235
|
[26]
|
Liang, B., Zhao, Y.X. and Gu, N. (2020) Discontinuation of Oral Anticoagulation Therapy after Apparently Successful Atrial Fibrillation Ablation. Europace, 22, 1143-1144. https://doi.org/10.1093/europace/euaa038
|
[27]
|
Terricabras, M. and Verma, A. (2020) Stopping Oral Anticoagulation after Successful Ablation for Atrial Fibrillation: Reality or Fiction? Europace, 22, 1-2. https://doi.org/10.1093/europace/euz284
|
[28]
|
Liang, J.J., Dixit, S. and Santangeli, P. (2016) Mechanisms and Clinical Significance of Early Recurrences of Atrial Arrhythmias after Catheter Ablation for Atrial Fibrillation. World Journal of Cardiology, 8, 638-646.
https://doi.org/10.4330/wjc.v8.i11.638
|
[29]
|
Andrade, J.G., Khairy, P., Verma, A., et al. (2012) Early Recurrence of Atrial Tachyarrhythmias Following Radiofrequency Catheter Ablation of Atrial Fibrillation. Pacing and Clinical Electrophysiology, 35, 106-116.
https://doi.org/10.1111/j.1540-8159.2011.03256.x
|
[30]
|
Takigawa, M., Takahashi, A., Kuwahara, T., et al. (2014) Long-Term Follow-Up after Catheter Ablation of Paroxysmal Atrial Fibrillation: The Incidence of Recurrence and Progression of Atrial Fibrillation. Circulation Arrhythmia and Electrophysiology, 7, 267-273. https://doi.org/10.1161/CIRCEP.113.000471
|
[31]
|
McManus, D.D., Chong, J.W., Soni, A., Saczynski, J.S., Esa, N., Napolitano, C., et al. (2016) PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application. Journal of Cardiovascular Electrophysiology, 27, 51-57. https://doi.org/10.1111/jce.12842
|
[32]
|
Sepehri Shamloo, A., Bollmann, A., Dagres, N., Arya, A. and Hindricks, G. (2020) Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere. Journal of the American College of Cardiology, 75, 1364-1365.
https://doi.org/10.1016/j.jacc.2019.10.063
|
[33]
|
Seshadri, D.R., Bittel, B., Browsky, D., Houghtaling, P., Drummond, C.K., Desai, M.Y., et al. (2020) Accuracy of Apple Watch for Detection of Atrial Fibrillation. Circulation, 141, 702-703.
https://doi.org/10.1161/CIRCULATIONAHA.119.044126
|
[34]
|
Koshy, A.N., Sajeev, J.K., Nerlekar, N., Brown, A.J., Rajakariar, K., Zureik, M., et al. (2018) Smart Watches for Heart Rate Assessment in Atrial Arrhythmias. International Journal of Cardiology, 266, 124-127.
https://doi.org/10.1016/j.ijcard.2018.02.073
|
[35]
|
Kaplan, R.M., Koehler, J., Ziegler, P.D., Sarkar, S., Zweibel, S. and Passman, R.S. (2019) Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score. Circulation, 140, 1639-1646.
https://doi.org/10.1161/CIRCULATIONAHA.119.041303
|
[36]
|
Verma, A., Ha, A.C.T., Kirchhof, P., et al. (2018) The Optimal Anticoagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) Trial. American Heart Journal, 197, 124-132.
https://doi.org/10.1016/j.ahj.2017.12.007
|